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Identification of ADRs through “Triggers” 
What are “Triggers”? 
The use of “triggers,” or clues, to identify adverse drug reaction (ADRs) is an effective method for measuring 
the overall level of harm from medications in a health care organisation. 
 
What is an Adverse Drug Reaction (ADR)? 
The World Health Organization (WHO) Collaborating Centers for International Drug Monitoring 
defines an adverse drug reaction (ADR) as follows: 
“Noxious and unintended and occurs at doses used in man for prophylaxis, diagnosis, therapy, or modification 
of physiologic functions.” 
— WHO Publication DEM/NC/84.153(E), June 1984 
The WHO definition includes ADRs caused by medication errors. Medication errors can occur at any stage in 
the medication system — from ordering through administering the drug to the patient. Some medication errors 
are harmless, some cause injury, and some are “near misses” (that is, they do not cause injury to the patient, 
either by chance or because they are intercepted before the medication is administered). 
Certain drugs or lab tests/results serve as clues to ADRs. The following is a list of triggers that organisations 
have found to be the most useful clues that an ADR has occurred. 
 
Vitamin K  
If Vitamin K was used as a response to a prolonged prothrombin time or elevated International Normalized 
Ration (INR) levels, it may signal an ADR. If either lab value is high, review the chart for evidence of bleed-
ing. Look in the lab reports for a drop in haematocrit or  stool positive for occult blood. Check the progress 
notes for evidence of excessive bruising or gastrointestinal bleeding. Less likely, a haemorrhagic stroke or 
other internal bleeding may have occurred. If any of these is found, it is likely that an ADR has occurred. 
 
Flumazenil  
This drug reverses benzodiazepine overdose. Determine why the drug was used. If hypotension or marked, 
prolonged sedation occurred following benzodiazepine administration, an ADR may have occurred. 
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Naloxone  
This is a potent narcotic antagonist. Its  use frequently indicates over dosage of  narcotics like Morphine, 
Pethidine or Fentanyl. If Naloxone was used and the patient's condition changed, excessive narcotic administra-
tion, which is an ADR, probably has occurred. 
 
Anti-diarrhoeal 
Look for antibiotic-caused infections of Clostridium difficile. If significant diarrhoea occurred in a patient re-
ceiving multiple antibiotics, it is likely that an ADR has occurred. 
 
Sodium Polystyrene (Kayexalate) 
Sodium polystyrene sulfonate is used in the treatment of hyperkalemia. Look for the reason for hyperkalemia 
and whether the patient had been receiving potassium or potassium sparing drugs. Administration of Kayexalate 
may be in response to an overdose of potassium, which would be an ADR. 
 
Dextrose Water 25% 
Low serum glucose does not necessarily mean an ADR has occurred. Look for signs or symptoms of hypoglyce-
mia in the nursing notes. Review patient profile to find order for insulin or oral hypoglycemic agents adminis-
tered prior to D25W administration. 
 
Rising Serum Creatinine 
Certain drugs like aminoglycosides, diuretics, NSAIDs, other antibiotics and antihypertensives can produce 
nephrotoxicity, which may become evident when serum creatinine levels start rising. If interventions were re-
quired to correct renal problems, an ADR may have occurred.  
 
Hydrocortisone +/- Clemastine 
The steroid injection with or without antihistamine is often used in managing a drug/dye hypersensitivity reac-
tion. Closely review drug profile for identification of such drug, also the discontinuation of offending drug often 
provides a clue. Check if the patient has undergone a diagnostic procedure in which a dye was used. 
 
Abrupt Cessation of Medication 
In the order sets, "hold" or "stop" medication orders frequently indicate that an ADR has occurred. E.g. holding 
Atenolol as a response to bradycardia. 
 
Transfer to a Higher Level of Care 
Transfer of a patient to a higher level of care is only a clue that an ADR may have occurred.  When reviewing 
this trigger, look for the reasons for the transfer and the change in condition. For example, in the case a patient 
with COPD is transferred to intensive care following respiratory arrest and intubation,  it would not be an ADR. 
But if it was caused by use of a narcotic or sedative, it would be an ADR.  
 
Reference: (2004) Institute for Healthcare Improvement  
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Drug Induced Fever 
 
Drug fever can be defined as "a disorder characterised by fever coinciding with the administration of the drug 
and disappearing after the discontinuation of the drug, when no other cause for the fever is evident after a care-
ful physical examination and laboratory investigation". 
 
Mechanisms: 
The mechanisms of drug fever are multiple and, in many cases, are poorly or incompletely understood. How-
ever, most authorities classify drug-related fevers into four broad categories: 
• Hypersensitivity reactions; 
• Altered thermoregulatory mechanisms; 
• Directly related to administration of the drug; 
• Idiosyncratic reactions. 
 
1. Fever associated with hypersensitivity:  
Hypersensitivity is the most common cause of drug fever. Various mechanisms can cause fever, including the 
formation of circulating antibody-antigen complexes and/or a T-cell immune response provoked by a drug or 
its metabolites. Fever may be the sole manifestation of a hypersensitivity reaction. However, rash, urticaria, 
hepatic or renal dysfunction, pulmonary involvement, mucosal ulceration, and haematologic abnormalities are 
not uncommon accompanying events. Withdrawal of the offending drug usually results in defervescence 
within 72 to 96 hours which helps to confirm the diagnosis, but delays of five to seven days have been ob-
served. 
Although virtually any drug is capable of causing fever via a hypersensitivity mechanism, following drugs de-
serve special mention: 
Anticonvulsants: Anticonvulsants like Carbamazepine and Phenytoin, are common causes of drug fever 
Antimicrobial agents: Antimicrobials are the most common drugs to be prescribed for febrile illnesses; they 
are also the most common cause of drug fever, accounting for approximately one-third of episodes. This espe-
cially applies to beta-lactams, sulfonamides and nitrofurantoin. Drug fever due to an antimicrobial agent can 
cause enormous clinical confusion because the return of a fever in an infected patient who has defervesced on 
antimicrobial treatment may be misinterpreted as a failure of the infection to respond.  
Allopurinol: It is an uncommon but important cause of drug fever. It is usually prescribed for the prevention 
of gout but is also used to diminish tumor lysis syndrome in patients receiving chemotherapy for malignancy. 
Allopurinol-induced fever is often accompanied by hepatotoxicity, deterioration of renal function, severe rash, 
and eosinophilia. Allopurinol should always be considered in the differential diagnosis of fever in patients tak-
ing the drug. There is probably a genetic predisposition and the reaction is more likely to occur in the presence 
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of drug accumulation or if taken along with thiazide diuretics. 2. Fever due to altered thermoregulation: 
A wide array of drugs can cause fever by disrupting the normal thermoregulatory mechanisms of the body. 
Body temperature is primarily regulated by the anterior hypothalamus, balancing heat loss via the periphery 
against heat production by the tissues. Example of drugs include: 
Exogenous thyroid hormone, drugs with anticholinergic activity, such as tricyclic antidepressants, Atropine, 
antihistamines, phenothiazines, and butyrophenone tranquilizers. Marked hyperthermia can ensue when these 
drugs are taken in combination. Oligohydrosis and hyperthermia has also been reported with the antiepileptic 
drug, zonisamide. 
Sympathomimetic agents such as amphetamines, cocaine, and related agents disturb hypothalamic function 
and effector mechanisms by causing peripheral vasoconstriction. 
3. Fever associated with drug administration: 
The parenteral administration of a wide variety of drugs can directly lead to fever. Solutions containing drugs 
can become contaminated with endotoxin or other exogenous pyrogens. Fever can also accompany a chemical 
phlebitis caused by drug administration, and local inflammation and/or sterile abscesses can occur at sites of 
injection. Many routine vaccinations are associated with low-grade fever for 48 hours or less. 
4. Fever due to an idiosyncratic reaction: 
Febrile idiosyncratic drug reactions are a heterogeneous category of drug-induced fevers. These reactions in-
clude unpredictable syndromes and genetic disorders, and there is some overlap with hypersensitivity phenom-
ena. E.g. Malignant Hyperthermia, neuroleptic malignant syndrome, serotonin syndrome and G6PD defi-
ciency. 
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Adverse Drug Reaction Alert! 
The Pharmacy and Therapeutics Committee of AKUH has cautioned health care professionals about the increasing re-
ports of bleeding episodes with the use of Enoxaparin. Most of the times the bleeding event and its further complica-
tions are preventable, provided that: 
• The dose is appropriate as per body weight, 
• The dose is adjusted in renal impairment, 
• Hemoglobin and Platelet count is monitored, 
• The correct administration technique is followed, 
• Close monitoring is done if patient is concurrently taking other Antithrombotic/anticoagulant mediations, 
• Patient is continuously monitored for sign and symptoms of bleeding, 
• The drug is NOT used in case of spinal/epidural analgesia and if spinal puncture is to be done, 
• The drug is discontinued if “Heparin Induced Thrombocytopenia” (HIT) is suspected 
Report ADRs - These are Crucial for Patient Safety 
